BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conlon N, Ford D. A systems-approach to NAD+ restoration. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.114946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Minazzato G, Marangoni E, Fortunato C, Petrelli R, Cappellacci L, Del Bello F, Sorci L, Gasparrini M, Piacente F, Bruzzone S, Raffaelli N. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase. Molecules 2023;28:961. [DOI: 10.3390/molecules28030961] [Reference Citation Analysis]
2 Conlon NJ. The Role of NAD+ in Regenerative Medicine. Plastic & Reconstructive Surgery 2022;150:41S-48S. [DOI: 10.1097/prs.0000000000009673] [Reference Citation Analysis]
3 Mark PR. NAD+ deficiency in human congenital malformations and miscarriage: A new model of pleiotropy. Am J Med Genet A 2022;188:2834-49. [PMID: 35484986 DOI: 10.1002/ajmg.a.62764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Beirowski B. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration. Neurobiol Dis 2022;:105751. [PMID: 35569720 DOI: 10.1016/j.nbd.2022.105751] [Reference Citation Analysis]